CD79A (P11912) variants and mutations
CD79A (also known as P11912) is a human protein-coding gene encoding a b-cell antigen receptor complex-associated protein alpha chain protein. Together with CD79B, it carries the intracellular signaling motifs that allow the B-cell receptor to transmit antigen-binding signals. Biallelic loss-of-function variants can block B-cell development and cause agammaglobulinemia. This analysis covers 581 CD79A variants and mutations. Of these, 89% have computational variant effect predictions. Disease context includes isolated agammaglobulinemia, agammaglobulinemia, and autosomal agammaglobulinemia. Example CD79A variants include M1?, P2L, and P2S.
Variant analysis overview
- Gene: CD79A
- Protein: P11912
- UniProt accession: P11912
- Organism: Homo sapiens
- Variants analyzed: 581
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 249 unspecified-consequence records; 194 missense variants; 91 synonymous variants; 1 splice acceptor variant; 24 frameshift variants; 3 splice-region variants; 5 in-frame deletions; 13 stop-gained variants; 1 in-frame insertions
- Prediction scores: 516 variants have prediction scores (89% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: isolated agammaglobulinemia, agammaglobulinemia, autosomal agammaglobulinemia, diffuse large B-cell lymphoma, colorectal adenocarcinoma, gliomatosis cerebri, cutaneous melanoma, immunodeficiency disease, B-cell chronic lymphocytic leukemia, plasma cell myeloma, esophageal squamous cell carcinoma, breast carcinoma.
Protein structure and variant hotspots
- Protein features: 1 transmembrane segments; 2 domains; 10 post-translational modification sites.
- Structural context: 320 variants have structural context.
- PTM context: 30 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable CD79A variants
Examples include M1?, P2L, P2S, P2H, G3A, G3G, G4C, G4S. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1?, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- P2L (p.Pro2Leu), cosmic curated COSV55738, TOPMed rs2074193640, REVEL 0.28, CADD 19.80
- P2S (p.Pro2Ser), gnomAD 19-41877308-C-T, REVEL 0.14, CADD 8.81
- P2H (p.Pro2His), gnomAD 19-41877309-C-A, REVEL 0.32, CADD 22.20
- G3A (p.Gly3Ala), rs782206373, ClinGen CA9465478, ClinVar RCV002016343, ExAC rs782206373, REVEL 0.22, CADD 12.30, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- G3G (p.Gly3Gly), rs1555843083, gnomAD 19-41877313-G-T, CADD 7.62
- G4C (p.Gly4Cys), ExAC rs782355570, gnomAD rs782355570, REVEL 0.24, CADD 22.10
- G4S (p.Gly4Ser), ExAC rs782355570, gnomAD rs782355570, REVEL 0.22, CADD 12.10
- G4D (p.Gly4Asp), gnomAD 19-41877315-G-A, REVEL 0.26, CADD 20.70
- G4V (p.Gly4Val), gnomAD 19-41877315-G-T, REVEL 0.24, CADD 20.30
- G4G (p.Gly4Gly), rs782195967, gnomAD 19-41877316-T-G, CADD 8.45
- P5S (p.Pro5Ser), rs146480366, ClinGen CA9465482, cosmic curated COSV10454, ClinVar RCV004218636, REVEL 0.10, CADD 4.77, Uncertain significance, not specified
- P5P (p.Pro5Pro), rs782032977, gnomAD 19-41877319-A-C, CADD 6.00
- G6E (p.Gly6Glu), gnomAD 19-41877321-G-A, REVEL 0.10, CADD 1.37
- G6G (p.Gly6Gly), rs782109582, gnomAD 19-41877322-A-C, CADD 7.59
- V7I (p.Val7Ile), gnomAD 19-41877323-G-A, REVEL 0.10, CADD 2.91
- V7V (p.Val7Val), gnomAD 19-41877325-C-A, CADD 4.40
- L8P (p.Leu8Pro), gnomAD 19-41877327-T-C, REVEL 0.20, CADD 11.90
- L8L (p.Leu8Leu), rs2123301467, gnomAD 19-41877328-C-T, CADD 5.25
- Q9R (p.Gln9Arg), ExAC rs781968364, gnomAD rs781968364, REVEL 0.11, CADD 0.12
- Q9Q (p.Gln9Gln), rs2074193909, gnomAD 19-41877331-A-G, CADD 6.67
- A10T (p.Ala10Thr), rs371184689, ClinGen CA248732, cosmic curated COSV55739, ClinVar RCV000120483, REVEL 0.07, CADD 14.70, Conflicting interpretations, not specified; Agammaglobulinemia 3, autosomal recessive
- A10V (p.Ala10Val), gnomAD rs1555843091, REVEL 0.11, CADD 1.69
- A10A (p.Ala10Ala), rs782716159, gnomAD 19-41877334-T-C, CADD 6.97
- L11L (p.Leu11Leu), gnomAD 19-41877335-C-T, CADD 6.95
- L11P (p.Leu11Pro), gnomAD 19-41877336-T-C, REVEL 0.31, CADD 1.01
- P12S (p.Pro12Ser), cosmic curated COSV55738, gnomAD rs1555843092, REVEL 0.21, CADD 17.40
- A13T (p.Ala13Thr), 1000Genomes rs538437053, ExAC rs538437053, gnomAD rs538437053, REVEL 0.15, CADD 19.30
- T14T (p.Thr14Thr), gnomAD 19-41877346-C-G, CADD 5.39
- I15F (p.Ile15Phe), Ensembl rs1555843097
- I15M (p.Ile15Met), NCI-TCGA Cosmic COSV5573, cosmic curated COSV55738, Ensembl rs2074194075, Variant assessed as somatic; moderate impact.
- I15V (p.Ile15Val), Ensembl rs1555843097, REVEL 0.06, CADD 5.26
- I15T (p.Ile15Thr), gnomAD 19-41877348-T-C, REVEL 0.15, CADD 9.97
- F16C (p.Phe16Cys), cosmic curated COSV55740, ExAC rs782558988, gnomAD rs782558988, REVEL 0.31, CADD 21.40
- F16L (p.Phe16Leu), gnomAD 19-41877350-T-C, REVEL 0.09, CADD 9.89
- F16F (p.Phe16Phe), gnomAD 19-41877352-C-T, CADD 6.52
- L17F (p.Leu17Phe), TOPMed rs2074194117
- L17P (p.Leu17Pro), cosmic curated COSV10583, gnomAD rs1555843103, REVEL 0.43, CADD 24.80
- L17L (p.Leu17Leu), gnomAD 19-41877355-C-A, CADD 6.38
- L18F (p.Leu18Phe), ExAC rs782760214, gnomAD rs782760214, REVEL 0.18, CADD 3.59
- L18I (p.Leu18Ile), ExAC rs782760214, gnomAD rs782760214, REVEL 0.30, CADD 2.38
- L18R (p.Leu18Arg), gnomAD rs1555843106, REVEL 0.40, CADD 23.90
- L18L (p.Leu18Leu), rs141033669, gnomAD 19-41877358-C-A, CADD 8.68
- F19C (p.Phe19Cys), TOPMed rs1449893471, REVEL 0.27, CADD 23.70
- F19L (p.Phe19Leu), Ensembl rs2074194236
- F19F (p.Phe19Phe), rs1357221630, gnomAD 19-41877361-C-T, CADD 9.33
- L20L (p.Leu20Leu), rs374135887, gnomAD 19-41877364-G-A, CADD 8.43
- L21L (p.Leu21Leu), rs1044944143, gnomAD 19-41877365-C-T, CADD 2.62
- S22T (p.Ser22Thr), rs1600629998, ClinGen CA406032179, ClinVar RCV000822533, TOPMed rs1600629998, AlphaMissense 0.10, MetaLR 0.36, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- S22P (p.Ser22Pro), gnomAD 19-41877368-T-C, REVEL 0.45, MetaLR 0.44
- S22F (p.Ser22Phe), gnomAD 19-41877369-C-T, REVEL 0.29, MetaLR 0.39
- A23P (p.Ala23Pro), TOPMed rs2074194407
- A23A (p.Ala23Ala), rs1555843115, gnomAD 19-41877373-T-G, CADD 7.38
- V24A (p.Val24Ala), Ensembl rs2123301604, REVEL 0.09, CADD 10.60
- Y25H (p.Tyr25His), gnomAD rs1555843119, REVEL 0.12, CADD 15.50
- Y25N (p.Tyr25Asn), NCI-TCGA Cosmic COSV9970, cosmic curated COSV99701, Variant assessed as somatic; moderate impact.
- Y25C (p.Tyr25Cys), gnomAD 19-41877378-A-G, REVEL 0.06, MetaLR 0.13
- L26M (p.Leu26Met), gnomAD rs1555843121, REVEL 0.27, CADD 17.50
- L26L (p.Leu26Leu), gnomAD 19-41877380-C-T, CADD 8.98
- G27A (p.Gly27Ala), TOPMed rs2074204427, Uncertain significance
- G27V (p.Gly27Val), rs2074204427, ClinGen CA406033964, ClinVar RCV001295939, TOPMed rs2074204427, AlphaMissense 0.25, MetaLR 0.54, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- G27D (p.Gly27Asp), gnomAD 19-41878990-G-A, REVEL 0.54, MetaLR 0.54
- G27G (p.Gly27Gly), gnomAD 19-41878991-C-A, CADD 4.54
- P28L (p.Pro28Leu), gnomAD 19-41878990-GC-G, CADD 14.90
- P28P (p.Pro28Pro), gnomAD 19-41878994-T-A, CADD 3.60
- G29R (p.Gly29Arg), NCI-TCGA Cosmic COSV5573, cosmic curated COSV55738, Variant assessed as somatic; moderate impact.
- G29V (p.Gly29Val), gnomAD 19-41878986-ACAGG, CADD 25.00
- p.Gly29 Gln31del, gnomAD 19-41878993-CTGGG, CADD 16.60
- G29E (p.Gly29Glu), gnomAD 19-41878996-G-A, REVEL 0.30, MetaLR 0.28
- G29G (p.Gly29Gly), gnomAD 19-41878997-G-T, CADD 5.47
- C30Y (p.Cys30Tyr), TOPMed rs1263805787, gnomAD rs1263805787, REVEL 0.36, CADD 23.30
- C30A (p.Cys30Ala), gnomAD 19-41878994-TG-T, CADD 16.90
- C30S (p.Cys30Ser), gnomAD 19-41878998-T-A, REVEL 0.15, MetaLR 0.25
- C30C (p.Cys30Cys), gnomAD 19-41879000-C-T, CADD 12.40
- Q31R (p.Gln31Arg), cosmic curated COSV55739, Ensembl rs2074204480, REVEL 0.30, CADD 22.50
- Q31Q (p.Gln31Gln), gnomAD 19-41879003-G-A, CADD 8.89
- A32P (p.Ala32Pro), gnomAD 19-41879002-AG-A, CADD 25.10
- A32T (p.Ala32Thr), gnomAD 19-41879004-G-A, REVEL 0.19, MetaLR 0.28
- A32G (p.Ala32Gly), gnomAD 19-41879005-C-G, REVEL 0.37, MetaLR 0.37
- L33R (p.Leu33Arg), gnomAD 19-41879008-T-G, REVEL 0.81, MetaLR 0.61
- L33Q (p.Leu33Gln), gnomAD 19-41879008-T-A, REVEL 0.76, MetaLR 0.60
- L33P (p.Leu33Pro), gnomAD 19-41879008-T-C, REVEL 0.72, MetaLR 0.47
- L33L (p.Leu33Leu), rs370167849, gnomAD 19-41879009-G-A, CADD 8.30
- M35R (p.Met35Arg), gnomAD 19-41879014-T-G, REVEL 0.06, MetaLR 0.13
- H36R (p.His36Arg), Ensembl rs112543324
- H36H (p.His36His), gnomAD 19-41879018-C-T, CADD 0.51
- K37R (p.Lys37Arg), gnomAD 19-41879020-A-G, REVEL 0.02, MetaLR 0.11
- K37N (p.Lys37Asn), gnomAD 19-41879021-G-T, REVEL 0.06, MetaLR 0.18
- V38I (p.Val38Ile), gnomAD rs1555843451
- V38F (p.Val38Phe), gnomAD 19-41879022-G-T, REVEL 0.09, MetaLR 0.16
- P39R (p.Pro39Arg), 1000Genomes rs536960351, ExAC rs536960351, gnomAD rs536960351, REVEL 0.33, CADD 16.20
- P39S (p.Pro39Ser), rs1555843453, NCI-TCGA Cosmic COSV9970, cosmic curated COSV99702, gnomAD rs1555843453, AlphaMissense 0.28, MetaLR 0.46, Variant assessed as somatic; moderate impact.
- A40V (p.Ala40Val), gnomAD rs1555843457, REVEL 0.16, CADD 16.00
- S41* (p.Ser41Ter), gnomAD 19-41879032-C-A, CADD 34.00
- L42L (p.Leu42Leu), rs782194733, gnomAD 19-41879034-T-C, CADD 1.55
- M43I (p.Met43Ile), TOPMed rs2074204738, gnomAD rs2074204738, REVEL 0.04, CADD 0.00
- M43K (p.Met43Lys), rs782421590, ClinGen CA9465520, ClinVar RCV001339065, ExAC rs782421590, REVEL 0.01, CADD 16.80, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- M43T (p.Met43Thr), ExAC rs782421590, TOPMed rs782421590, gnomAD rs782421590, REVEL 0.05, CADD 2.56, Likely benign, not specified
- V44L (p.Val44Leu), ExAC rs782253551, TOPMed rs782253551, gnomAD rs782253551, REVEL 0.36, CADD 22.00
- S45T (p.Ser45Thr), rs199603062, ClinGen CA9465523, ClinVar RCV001041092, 1000Genomes rs199603062, REVEL 0.18, CADD 0.77, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- S45R (p.Ser45Arg), gnomAD 19-41879045-C-A, REVEL 0.17, MetaLR 0.31
- L46P (p.Leu46Pro), rs2074204859, ClinGen CA406034182, ClinVar RCV001325286, Ensembl rs2074204859, REVEL 0.07, CADD 11.80, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- G47E (p.Gly47Glu), TOPMed rs1390442945
- E48G (p.Glu48Gly), ExAC rs782091793, gnomAD rs782091793, REVEL 0.27, CADD 17.30
- D49N (p.Asp49Asn), TOPMed rs1383009914
- D49E (p.Asp49Glu), gnomAD 19-41879057-C-A, REVEL 0.06, MetaLR 0.05
- D49D (p.Asp49Asp), rs782302503, gnomAD 19-41879057-C-T, CADD 0.89
- A50T (p.Ala50Thr), rs557160710, cosmic curated COSV10583, TOPMed rs557160710, gnomAD rs557160710, REVEL 0.39, CADD 23.20, Variant assessed as somatic; moderate impact.
- A50A (p.Ala50Ala), rs1600631081, gnomAD 19-41879060-C-T, CADD 7.84
- H51P (p.His51Pro), rs781936282, NCI-TCGA Cosmic COSV5573, cosmic curated COSV55739, ExAC rs781936282, REVEL 0.15, CADD 0.47, Variant assessed as somatic; moderate impact.
- H51Y (p.His51Tyr), gnomAD rs1555843473, REVEL 0.08, CADD 6.88
- H51H (p.His51His), gnomAD 19-41879063-C-T, CADD 5.74
- F52L (p.Phe52Leu), NCI-TCGA Cosmic COSV5573, Variant assessed as somatic; moderate impact.
- Q53* (p.Gln53Ter), gnomAD rs1555843479
- Q53L (p.Gln53Leu), gnomAD rs2074205131, REVEL 0.12, CADD 0.03
- C54C (p.Cys54Cys), gnomAD 19-41879072-C-T, CADD 4.59
- P55L (p.Pro55Leu), rs764758292, ClinGen CA9465527, cosmic curated COSV55739, ClinVar RCV001875606, REVEL 0.09, CADD 0.00, Conflicting interpretations, not specified; Agammaglobulinemia 3, autosomal recessive
- P55P (p.Pro55Pro), rs144847382, gnomAD 19-41879075-G-A, CADD 0.46
- H56H (p.His56His), rs781858171, gnomAD 19-41879078-C-T, CADD 5.70
- S58I (p.Ser58Ile), ExAC rs782133300, TOPMed rs782133300, gnomAD rs782133300
- S58N (p.Ser58Asn), ExAC rs782133300, TOPMed rs782133300, gnomAD rs782133300, REVEL 0.01, CADD 0.52
- S58S (p.Ser58Ser), gnomAD 19-41879084-C-T, CADD 8.85
- S59N (p.Ser59Asn), cosmic curated COSV55738, Ensembl rs2074205255, REVEL 0.06, CADD 0.93
- S59del (p.Ser59del), rs868958703, gnomAD 19-41879081-TAGC-, CADD 9.47
- N60S (p.Asn60Ser), rs370313642, ClinGen CA9465531, cosmic curated COSV10959, ClinVar RCV001300381, REVEL 0.10, CADD 0.06, Uncertain significance, not specified; Agammaglobulinemia 3, autosomal recessive
- N60N (p.Asn60Asn), gnomAD 19-41879090-C-T, CADD 2.30
- N61I (p.Asn61Ile), rs2074205317, ClinGen CA406034290, ClinVar RCV001313454, Ensembl rs2074205317, REVEL 0.11, CADD 10.10, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- N61del (p.Asn61del), rs1555843491, gnomAD 19-41879086-GCAA-, CADD 6.51
- N61N (p.Asn61Asn), rs781792305, gnomAD 19-41879093-C-T, CADD 0.39
- A62T (p.Ala62Thr), rs782467376, ClinGen CA9465533, NCI-TCGA Cosmic COSV5573, ClinVar RCV001036083, REVEL 0.18, CADD 0.01, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- N63I (p.Asn63Ile), rs151224661, ClinGen CA406034302, ClinVar RCV002662680, 1000Genomes rs151224661, REVEL 0.30, CADD 22.40, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- N63K (p.Asn63Lys), ESP rs140047688, ExAC rs140047688, TOPMed rs140047688, gnomAD rs140047688, REVEL 0.14, CADD 0.00, Likely benign
- N63S (p.Asn63Ser), rs151224661, ClinGen CA9465534, cosmic curated COSV55738, ClinVar RCV000801006, REVEL 0.21, CADD 16.30, Uncertain significance, Agammaglobulinemia 3, autosomal recessive; not specified
- N63del (p.Asn63del), gnomAD 19-41879095-CCAA-, CADD 11.60
- N63N (p.Asn63Asn), rs140047688, gnomAD 19-41879099-C-T, CADD 0.10
- V64I (p.Val64Ile), rs374041941, ClinGen CA9465536, cosmic curated COSV55738, ClinVar RCV003077222, REVEL 0.05, CADD 0.51, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- T65T (p.Thr65Thr), gnomAD 19-41879105-C-G, CADD 0.33
- W66* (p.Trp66Ter), rs1568801716, ClinGen CA406034322, ClinVar RCV000691714, Ensembl rs1568801716, Pathogenic
- R68C (p.Arg68Cys), rs782657641, ClinGen CA9465537, NCI-TCGA Cosmic COSV9970, cosmic curated COSV99702, REVEL 0.17, CADD 23.00, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- R68H (p.Arg68His), rs782507150, ClinGen CA9465538, NCI-TCGA Cosmic COSV5573, cosmic curated COSV55739, REVEL 0.10, CADD 3.90, Conflicting interpretations, not provided; Agammaglobulinemia 3, autosomal recessive
- R68R (p.Arg68Arg), rs150297110, gnomAD 19-41879114-C-T, CADD 6.59
- V69A (p.Val69Ala), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V69I (p.Val69Ile), rs782563209, NCI-TCGA Cosmic COSV5573, cosmic curated COSV55738, ExAC rs782563209, REVEL 0.01, CADD 0.00, Variant assessed as somatic; moderate impact.
- V69V (p.Val69Val), gnomAD 19-41879117-C-T, CADD 5.20
- L70H (p.Leu70His), gnomAD rs1555843509, REVEL 0.24, CADD 18.90
- L70L (p.Leu70Leu), rs2074205615, gnomAD 19-41879120-C-T, CADD 3.42
- H71R (p.His71Arg), TOPMed rs2074205650, REVEL 0.01, CADD 6.47
- H71Y (p.His71Tyr), TOPMed rs2074205632
- H71H (p.His71His), gnomAD 19-41879123-T-C, CADD 0.17
- G72G (p.Gly72Gly), gnomAD 19-41879126-C-G, CADD 4.47
- N73T (p.Asn73Thr), Ensembl rs2074205671, REVEL 0.39, CADD 23.80
- Y74Y (p.Tyr74Tyr), rs1460027871, gnomAD 19-41879132-C-T, CADD 4.18
- T75K (p.Thr75Lys), rs199967393, ClinGen CA406034382, ClinVar RCV000689793, 1000Genomes rs199967393, REVEL 0.13, CADD 21.30, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- T75M (p.Thr75Met), rs199967393, ClinGen CA9465541, ClinVar RCV001035807, 1000Genomes rs199967393, REVEL 0.11, CADD 21.50, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- T75S (p.Thr75Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- T75T (p.Thr75Thr), rs1487166711, gnomAD 19-41879135-G-A, CADD 0.62
- W76G (p.Trp76Gly), gnomAD 19-41879135-GT-G, CADD 22.90
- W76R (p.Trp76Arg), gnomAD 19-41879136-T-C, REVEL 0.37, MetaLR 0.55
- W76* (p.Trp76Ter), gnomAD 19-41879138-G-A, CADD 33.00
- P77T (p.Pro77Thr), TOPMed rs1555843514, gnomAD rs1555843514, REVEL 0.22, CADD 11.50
- P77S (p.Pro77Ser), gnomAD 19-41879139-C-T, REVEL 0.19, MetaLR 0.26
- P77L (p.Pro77Leu), gnomAD 19-41879140-C-T, REVEL 0.19, MetaLR 0.35
- P78L (p.Pro78Leu), NCI-TCGA Cosmic COSV5573, cosmic curated COSV55738, REVEL 0.10, CADD 16.80, Variant assessed as somatic; moderate impact.
- P78R (p.Pro78Arg), ESP rs372519166, ExAC rs372519166, TOPMed rs372519166, gnomAD rs372519166, REVEL 0.10, CADD 13.70
- P78S (p.Pro78Ser), gnomAD 19-41879142-C-T, REVEL 0.04, MetaLR 0.17
- P78P (p.Pro78Pro), rs2074205803, gnomAD 19-41879144-T-G, CADD 0.69
- E79Q (p.Glu79Gln), gnomAD rs1555843521
- E79S (p.Glu79Ser), gnomAD 19-41879143-CT-C, CADD 0.17
- F80L (p.Phe80Leu), rs926961615, NCI-TCGA Cosmic COSV5573, cosmic curated COSV55738, TOPMed rs926961615, REVEL 0.10, CADD 0.31, Variant assessed as somatic; moderate impact.
- F80F (p.Phe80Phe), rs926961615, gnomAD 19-41879150-C-T, CADD 1.30
- L81S (p.Leu81Ser), rs2074205887, ClinGen CA406034424, ClinVar RCV003045436, Ensembl rs2074205887, REVEL 0.06, CADD 8.73, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- L81W (p.Leu81Trp), gnomAD 19-41879149-TC-T, CADD 12.80
- L81L (p.Leu81Leu), rs782026458, gnomAD 19-41879151-T-C, CADD 0.28
- G82R (p.Gly82Arg), gnomAD 19-41879154-G-C, REVEL 0.09, MetaLR 0.29
- P83L (p.Pro83Leu), cosmic curated COSV55739, ExAC rs782110924, TOPMed rs782110924, gnomAD rs782110924, REVEL 0.14, CADD 0.00
- P83P (p.Pro83Pro), rs1360629547, gnomAD 19-41879159-G-A, CADD 0.35
- G84D (p.Gly84Asp), gnomAD 19-41879161-G-A, REVEL 0.10, MetaLR 0.19
- G84G (p.Gly84Gly), rs782389366, gnomAD 19-41879162-C-T, CADD 7.03
- E85K (p.Glu85Lys), rs781949432, ClinGen CA9465547, ClinVar RCV002938625, ExAC rs781949432, REVEL 0.15, CADD 0.00, Uncertain significance, Agammaglobulinemia 3, autosomal recessive
- E85G (p.Glu85Gly), gnomAD 19-41879164-A-G, REVEL 0.06, MetaLR 0.11
Public CD79A analysis runs
- CD79A analysis run — CD79A (581 variants) — completed 2026-08-19